Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB8 | P28062 | 3/20 | 0.65 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.65 |
| ▸ | ESR1 | P03372 | 12/20 | 0.53 |
| ▸ | ESR2 | Q92731 | 12/20 | 0.53 |
| ▸ | APP | P05067 | 1/20 | 0.46 |
| ▸ | MIF | P14174 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.44 |
| ▸ | STS | P08842 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9757252 | 0.79 | PSMB8 (0.65) | PSMB8PSMB5NPC1RAB9A | |
| SCHEMBL21689039 | 0.79 | PSMB8 (0.65) | PSMB8PSMB5APPNPC1RAB9A | |
| SCHEMBL9797527 | 0.78 | PSMB8 (0.63) | PSMB8PSMB5 | |
| SCHEMBL9797235 | 0.77 | PSMB8 (0.61) | PSMB8PSMB5 | |
| SCHEMBL17265862 | 0.75 | ESR1 (0.61) | ESR1ESR2APPCA9STS | |
| SCHEMBL29999385 | 0.75 | ESR1 (0.61) | ESR1ESR2APPCA9STS | |
| SCHEMBL9757041 | 0.75 | PSMB8 (0.59) | PSMB8PSMB5CYP19A1NPC1RAB9A | |
| SCHEMBL8740097 | 0.74 | ESR1 (0.74) | ESR1ESR2APPCYP19A1NPC1 | |
| SCHEMBL27837395 | 0.74 | ESR1 (0.56) | ESR1ESR2APPCA9STS | |
| SCHEMBL548913 | 0.73 | PSMB8 (1.00) | PSMB8PSMB5NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1991019475-A2 | QUINOLINYL-BENZOHETEROBICYCLIC DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D¿4? | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1991-12-26 | — | — | WO | disclosed |
| US-5041453-A | Quinolinyl-benzoheterobicyclic derivatives as antagonists of leukotriene D4 | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1991-08-20 | — | — | US | disclosed |